This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McMahon, K. S. Articles by Fingar, V. H. Search for Related Content PubMed PubMed Citation Articles by McMahon, K. S. Articles by Fingar, V. H.

Effects of Photodynamic Therapy Using Mono-L-aspartyl Chlorin e₆ on Vessel Constriction, Vessel Leakage, and Tumor Response¹

Department of Surgery, Division of Surgical Oncology, University of Louisville, Louisville, Kentucky 40292

The effect of photodynamic therapy using mono-L-aspartyl chlorin e₆ (NPe6) on both direct cytotoxicity and vascular damage was examined. Sprague-Dawley rats bearing chondrosarcoma tumor were given i.v. injections of 5 or 10 mg/kg NPe6 and exposed to 135-J/cm² 664-nm laser light either 4 or 24 h after NPe6 injection. The percentage of viable tumor cells was estimated either immediately after the completion of light treatment or 24 h after treatment using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Measurements of arteriole constriction and venule leakage in normal cremaster tissues were made during and 1 h after the light treatment. Tumor response was evaluated for the 4 different NPe6 dose and time combinations. Both direct tumor cytotoxicity and vascular stasis were observed during light treatment. Vessel leakage did not occur. Blood flow stasis was a result of platelet aggregation and the mechanical obstruction of flow rather than vessel construction. The magnitude of direct cytotoxicity and vascular response was dependent on both the amount of NPe6 delivered and the delay between injection and light treatment. Tumor cure was found in animals either when given high NPe6 doses or when treated early after NPe6 injection. Treatment regimens which maximized the effect of both vascular stasis and direct tumor cytotoxicity were found to produce the best tumor response. Dose combinations which produced vascular stasis with minimal early cytotoxicity did not result in cure. The combined mechanisms of damage after photodynamic therapy using NPe6 suggests that this photosensitizer may have specific advantages for clinical use and provides a benchmark for the development of new photosensitizers.

¹ This investigation was supported by USPHS Grant CA51771 awarded by the National Cancer Institute, Department of Health and Human Services, by the Department of Surgery, and by the James Graham Brown Cancer Center.

² To whom requests for reprints should be addressed, at University of Louisville, Department of Surgery, James Graham Brown Cancer Center, 529 South Jackson Street, Louisville, KY 40292.

Received 12/14/93. Accepted 8/16/94.

This article has been cited by other articles:

				G. Yu, T. Durduran, C. Zhou, H.-W. Wang, M. E. Putt, H. M. Saunders, C. M. Sehgal, E. Glatstein, A. G. Yodh, and T. M. Busch Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy Clin. Cancer Res., May 1, 2005; 11(9): 3543 - 3552. [Abstract] [Full Text] [PDF]

				M. C. Luna, A. Ferrario, S. Wong, A. M. R. Fisher, and C. J. Gomer Photodynamic Therapy-mediated Oxidative Stress as a Molecular Switch for the Temporal Expression of Genes Ligated to the Human Heat Shock Promoter Cancer Res., March 1, 2000; 60(6): 1637 - 1644. [Abstract] [Full Text]

				B. W. Engbrecht, C. Menon, A. V. Kachur, S. M. Hahn, and D. L. Fraker Photofrin-mediated Photodynamic Therapy Induces Vascular Occlusion and Apoptosis in a Human Sarcoma Xenograft Model Cancer Res., September 1, 1999; 59(17): 4334 - 4342. [Abstract] [Full Text] [PDF]